Vertex Pharmaceuticals Incorporated vs Clear Secure Inc — how do they compare? Vertex Pharmaceuticals Incorporated trades at $481.47 (market cap $121.95B), while Clear Secure Inc trades at $57.03 (market cap $5.76B). The key difference: Vertex Pharmaceuticals Incorporated is far larger — about 21.2× Clear Secure Inc's market cap, and Clear Secure Inc pays a 1.05% dividend while Vertex Pharmaceuticals Incorporated pays none. Which is the better fit depends on your goals.
| VRTX | YOU | |
|---|---|---|
Market Cap | $121.95B | $5.76B |
Sector | Health | Technology |
52-Week High | $529.59 | $62.36 |
52-Week Low | $366.54 | $28.84 |
Enterprise Value | $116.69B | $5.07B |
Dividend Yield | — | 1.05% |
Trailing returns across standard periods
Latest headlines on both assets
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Read more on VRTX →Clear Secure operates a secure identity platform that uses biometrics—specifically eyes, face, and fingerprints—to automate and expedite identity verification. While its most visible application is the CLEAR Plus airport subscription service, the company functions as a broad-based identity layer for travel, healthcare, and digital services, aiming to replace physical IDs with a secure, biometric link.
Read more on YOU →